Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042650
Filing Date
2019-11-12
Accepted
2019-11-12 09:06:26
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ftsv-10q_20190930.htm 10-Q 2345804
2 EX-10.1 ftsv-ex101_54.htm EX-10.1 735237
3 EX-31.1 ftsv-ex311_8.htm EX-31.1 17995
4 EX-31.2 ftsv-ex312_6.htm EX-31.2 18532
5 EX-32.1 ftsv-ex321_9.htm EX-32.1 9464
6 EX-32.2 ftsv-ex322_7.htm EX-32.2 9439
7 GRAPHIC gewkgkzk54e0000002.jpg GRAPHIC 29455
8 GRAPHIC gewkgkzk54e0000001.jpg GRAPHIC 45323
  Complete submission text file 0001564590-19-042650.txt   6916019

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ftsv-20190930.xml EX-101.INS 1060867
10 XBRL TAXONOMY EXTENSION SCHEMA ftsv-20190930.xsd EX-101.SCH 44854
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ftsv-20190930_cal.xml EX-101.CAL 42061
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ftsv-20190930_def.xml EX-101.DEF 125737
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ftsv-20190930_lab.xml EX-101.LAB 349406
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ftsv-20190930_pre.xml EX-101.PRE 243064
Mailing Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 (650) 352-4150
Forty Seven, Inc. (Filer) CIK: 0001667633 (see all company filings)

EIN.: 474065674 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38554 | Film No.: 191206502
SIC: 2834 Pharmaceutical Preparations